Search

An inside look at the research of MSK's Dr. Michael Kharas, whose work on RNA biology is shedding new light on cancer.

… Wednesday, June 5, 2024 “The blueprint of life.” “The genetic code.” The metaphors we used to describe DNA make it sound almost sacred. Proteins, too, are revered. They are the “workhorses of the cell.” They make things happen. RNA, by contrast, has not been so exalted. It is simply “the messenger,”

Read about the research of Renhe Luo, winner of the 2024 GSK Chairman’s Prize, who studies gene enhancers.

… Thursday, August 29, 2024 Renhe Luo, PhD , who recently graduated from the Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) , has been awarded the 2024 Chairman’s Prize. The competitive award is presented annually and was established by  GSK’s Board of Trustees Chair Emeritus Louis

Lung cancer co-opts genes that normally help a fetus develop and evade the mother’s immune system — leading to poorer outcomes in female patients, an MSK research team has found.

… Monday, April 28, 2025 Lung cancer can co-opt genes that normally help a fetus develop and evade the mother’s immune system. And while these pregnancy-specific glycoproteins (PSGs) can get activated in the cancers of both men and women, female patients had poorer outcomes, a Memorial Sloan Kettering

In an extraordinary demonstration of excellence, positive results from two separate studies of new therapies for the treatment of advanced melanoma were presented at the plenary session of the 2011 annual meeting of the American Society of Clinical Oncology by Paul Chapman, MD, and Jedd Wolchok MD, PhD, members of Memorial Sloan Kettering Cancer Center's Melanoma and Sarcoma service, and lead authors on the studies along with collaborators from more than a one hundred cancer centers worldwide.

… Sunday, June 5, 2011 In an extraordinary demonstration of excellence, positive results from two separate studies of new therapies for the treatment of advanced melanoma were presented at the plenary session of the 2011 annual meeting of the American Society of Clinical Oncology by Paul Chapman, MD, and

The “pocket-creation method” is the latest advance in endoscopic submucosal dissection, a technique for the removal of early-stage gastrointestinal cancers, further boosting its superiority over the standard approach of using endoscopic mucosal resection.

… Monday, September 10, 2018 The “pocket-creation method” is the latest advance in endoscopic submucosal dissection, a technique for the removal of early-stage gastrointestinal cancers, further boosting its superiority over the standard approach of using endoscopic mucosal resection. Endoscopic submucosal

Memorial Sloan Kettering social workers Meredith Cammarata and Liz Blackler give advice to anyone who wants to offer support to someone they know with cancer.

… Monday, October 13, 2014 Summary Memorial Sloan Kettering social workers Meredith Cammarata and Liz Blackler give advice to anyone who wants to offer support to someone they know with cancer. After learning that a friend, colleague, or neighbor has cancer, you may wonder what you should do. You might

Learn about MSK’s expertise in treating vulvar and vaginal cancers, uterine sarcoma, uncommon ovarian cancers, and gestational trophoblastic disease.

… Friday, September 27, 2019 Summary Members of MSK’s gynecology oncology team are leaders in diagnosing and treating not only well-known gynecologic cancers but uncommon forms as well. In its annual listing of the country’s best hospitals,  U.S. News & World Report  ranked Memorial Sloan Kettering number

Learn how molecular analysis of Jason’s sarcoma led to a personalized immunotherapy treatment that dramatically improved his prognosis. MSK is a leader in treating sarcoma.

… Monday, July 18, 2022 Thirty-four-year-old Jason Mascolo put off getting the nagging pain in his leg checked out for years because he didn’t have health insurance. It wasn’t until he got a job with benefits — as a utility worker with Consolidated Edison — that he went to see a doctor. The news was not

Results from studies in cell cultures and mouse models suggest that the experimental targeted therapy PU-H71 may be effective against one of the most aggressive forms of breast cancer.

… Thursday, October 1, 2009 Summary Results from studies in cell cultures and mouse models suggest that the experimental targeted therapy PU-H71 may be effective against one of the most aggressive forms of breast cancer. Results from studies in cell cultures and mouse models suggest that the experimental

Active surveillance of prostate cancer is being increasingly utilized for men with low-risk cancer. But some men with potentially life-threatening cancers are being inadvertently enrolled in such programs, driving the need for more accurate decision-making tools such as the 4Kscore test developed at Memorial Sloan Kettering.

… Thursday, October 12, 2017 Active surveillance of prostate cancer is being increasingly utilized for men with low-risk cancer. But some men with potentially life-threatening cancers are being inadvertently enrolled in active surveillance programs, driving the need for more-accurate decision-making tools